Shaping T Cell – B Cell Collaboration in the Response to Human Immunodeficiency Virus Type 1 Envelope Glycoprotein gp120 by Peptide Priming

N. Kalaya Steede, Blake J. Rust, Md. Moyazzem Hossain, Lucy C. Freytag, James E. Robinson, Samuel J. LandryPLoS 2013 · DOI

Abstract

Prime-boost vaccination strategies are a promising avenue for achieving protective immunity against HIV. However, the mechanisms by which cellular immunity influences humoral responses remain poorly understood. This study investigates the relationship between CD4+ T-cell specificity and antibody specificity in response to the HIV-1 envelope glycoprotein gp120. By priming mice with specific peptides before protein immunization, researchers demonstrated that T-B cell collaborations can be shaped to target specific epitopes, though this can sometimes divert help away from protective conformational antibodies.

What Problem Does This Paper Address?

Designing an effective HIV vaccine is notoriously difficult because the virus's outer shell, gp120, is a moving target covered in "decoy" regions. While CD4+ T cells are essential for "helping" B cells mature and produce high-quality antibodies, the reciprocity of this relationship in a living system is not fully understood.

Does a T cell that recognizes a specific fragment only help a B cell that recognizes the same fragment? Understanding and manipulating this collaboration could allow researchers to force the immune system to ignore decoys and focus on "broadly neutralizing" sites, such as the CD4 binding site, which are critical for stopping the virus.

Methods

The authors immunized BALB/c mice with a specific variant of the HIV envelope protein called gp120dss378, designed to expose the CD4 binding site. The experimental groups included unprimed controls and groups primed with a single 20-mer peptide (either Peptide 2 from the N-terminus or Peptide 29 from the V3 loop) before the full protein boost.

Experimental timeline and group design for peptide priming and immunization.

To map the response, splenocytes were restimulated with a library of 38 overlapping peptides to measure the secretion of nine different cytokines. Pearson correlations were then used to determine if the intensity of a T-cell response to a specific peptide predicted the titer of specific antibodies in the same animal.

Key Insights and Ideas

  • The "Bulk" Deception: Total antibody levels correlated poorly with the overall T-cell response. However, conformational antibodies—those recognizing the protein's 3D shape or blocking CD4 binding—showed strong correlations with IL-2 and IL-5 production, suggesting high-quality antibodies require specific T-cell help.
  • Stochasticity vs. Determinism: Significant mouse-to-mouse variability suggests that immune responses are somewhat stochastic; whichever B-cell subset gets a "head start" recruits the available T-cell help, creating a self-reinforcing loop.
  • Priming as a Steering Wheel: Priming with a linear peptide successfully reshaped the collaboration. In primed mice, T-B cell correlations shifted almost entirely toward the primed peptide and its immediate neighbors.
  • The Cost of Focus: Priming with linear peptides eliminated the correlations between T cells and conformational antibodies. By giving "linear-seeking" B cells a head start, the researchers inadvertently diverted T-cell help away from B cells targeting complex, 3D-dependent sites.

Key Results

Analysis of the unprimed mice revealed that IL-2 and IL-5 were the primary drivers of T-B collaboration for conformational epitopes.

Correlation of cytokine responses with conformational antibody titers, highlighting the significant roles of IL-2 and IL-5 for CD4-blocking antibodies.

Specific priming results included:

  • Peptide 2 Priming: Shifted the immunological focus to the N-terminus, significantly elevating antibodies against Peptides 2 and 3.
  • Peptide 29 Priming: Focused the response on the V3 loop region.
  • Competitive Environment: In some groups, the success of one B-cell subset was negatively correlated with T-cell help for other regions, confirming a competition for limited T-cell resources.

Limitations and Future Work

While the study successfully "shaped" the response, peptide priming appeared to distract the immune system from making critical CD4-blocking antibodies. Future research should explore:

  1. Conformational Mimics: Priming with small, stable 3D structures that mimic the CD4 binding site rather than linear peptides.
  2. Adjuvant Optimization: Identifying chemical triggers that favor beneficial collaborations (like IL-2/IL-5).
  3. Human Translation: Determining if these T-B reciprocity patterns hold true in non-human primates or human clinical trials.

Summary updated

Abstract

Prime-boost vaccination regimes have shown promise for obtaining protective immunity to HIV. Poorly understood mechanisms of cellular immunity could be responsible for improved humoral responses. Although CD4+ T-cell help promotes B-cell development, the relationship of CD4+ T-cell specificity to antibody specificity has not been systematically investigated. Here, protein and peptide-specific immune responses to HIV-1 gp120 were characterized in groups of ten mucosally immunized BALB/c mice. Protein and peptide reactivity of serum antibody was tested for correlation with cytokine secretion by splenocytes restimulated with individual gp120 peptides. Antibody titer for gp120 correlated poorly with the peptide-stimulated T-cell response. In contrast, titers for conformational epitopes, measured as crossreactivity or CD4-blocking, correlated with average interleukin-2 and interleukin-5 production in response to gp120 peptides. Antibodies specific for conformational epitopes and individual gp120 peptides typically correlated with T-cell responses to several peptides. In order to modify the specificity of immune responses, animals were primed with a gp120 peptide prior to immunization with protein. Priming induced distinct peptide-specific correlations of antibodies and T-cells. The majority of correlated antibodies were specific for the primed peptides or other peptides nearby in the gp120 sequence. These studies suggest that the dominant B-cell subsets recruit the dominant T-cell subsets and that T-B collaborations can be shaped by epitope-specific priming.
BibTeX
@inproceedings{steede2013shaping,
  author = {N. Kalaya Steede and Blake J. Rust and Md. Moyazzem Hossain and Lucy C. Freytag and James E. Robinson and Samuel J. Landry},
  title = {{Shaping T Cell – B Cell Collaboration in the Response to Human Immunodeficiency Virus Type 1 Envelope Glycoprotein gp120 by Peptide Priming}},
  booktitle = {PLoS},
  year = {2013},
  doi = {10.1371/journal.pone.0065748},
}
Figure